Correlation Between Blueprint Medicines and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Vir Biotechnology, you can compare the effects of market volatilities on Blueprint Medicines and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Vir Biotechnology.
Diversification Opportunities for Blueprint Medicines and Vir Biotechnology
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Blueprint and Vir is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Vir Biotechnology
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.68 times more return on investment than Vir Biotechnology. However, Blueprint Medicines Corp is 1.47 times less risky than Vir Biotechnology. It trades about 0.07 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.02 per unit of risk. If you would invest 4,446 in Blueprint Medicines Corp on November 5, 2024 and sell it today you would earn a total of 6,807 from holding Blueprint Medicines Corp or generate 153.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Vir Biotechnology
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Vir Biotechnology |
Blueprint Medicines and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Vir Biotechnology
The main advantage of trading using opposite Blueprint Medicines and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |